Study aims to perfect bleeding control drug for joint replacements
NCT ID NCT05075200
First seen Jan 05, 2026 · Last updated Jun 11, 2026 · Updated 31 times
Summary
This study looked at how to best dose tranexamic acid (TXA), a drug that reduces bleeding, during hip or knee replacement surgery. Researchers tested two different dosing plans in 21 adults to see how the drug works in the body. The goal is to create clear dosing guidelines to lower blood loss and the need for transfusions after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTHROPLASTY, REPLACEMENT, KNEE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Conditions
Explore the condition pages connected to this study.